Company's Profile
Arovella Therapeutics Limited, an Australian biotech company, focuses on developing innovative therapies for oncology and central nervous system disorders. Their technologies include iNKT Cell Therapy and DKK1-CAR-iNKT, aiming to treat blood cancers and solid tumors. They also have approvals for Anagrelide in multiple regions and market ZolpiMist for short-term insomnia. Collaboration with Imperial College London enhances their research and development efforts.